Schizophrenia Rx Gets Stronger Warning
The US Food and Drug Administration (FDA) has strengthened a drug safety warning for a schizophrenia medication.
FDA Investigating Two Deaths Following Injection of Zyprexa Relprevv
The US Food and Drug Administration (FDA) is investigating two unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa Relprevv (olanzapine pamoate).
FDA Drug Safety Communication: Saphris
The U.S. Food and Drug Administration (FDA) is warning the public that serious allergic reactions have been reported with the use of the antipsychotic medication Saphris ( asenapine maleate ).
Medication Errors Resulting From Name Confusion
The U.S. Food and Drug Administration (FDA) is alerting the public to medication error reports in which patients were given risperidone ( Risperdal ) instead of ropinirole ( Requip ) and vice versa. In some cases, patients who took the wrong medication needed to be hospitalized.
Motherhood is About to Make You a Little Crazier
FDA notified healthcare professionals that the Pregnancy section of drug labels for the entire class of antipsychotic drugs has been updated.